Literature DB >> 22320283

Contemporary profile of oral manifestations of HIV/AIDS and associated risk factors in a Southeastern US clinic.

Irene Tamí-Maury1, James Willig, Sten Vermund, Pauline Jolly, Inmaculada Aban, Jeffrey Hill, Craig M Wilson.   

Abstract

BACKGROUND: Introduction of highly active antiretroviral therapy (HAART) has resulted in a significant decrease of oral manifestations (OMs). The profile and risk factors for OM in those individuals initiating HAART remain understudied in the Southeast of the United States, region of increasing HIV prevalence.
OBJECTIVE: To determine clinical, socio-demographic, and laboratory characteristics associated with the presence of OM among patients initiating HAART.
METHODS: Retrospective review of electronically captured data from patients initiating HAART at a Southeastern US clinic. Prevalence was determined, and risk factors for overall OM, oropharyngeal candidiasis (OPC), and all other OM were evaluated using logistic regression.
RESULTS: In our sample (n = 744), majority of individuals were males (75 percent), African-American (50 percent), mean age of 39 years, 42 percent of which reported sex with men (MSM). Two hundred sixty-six had some type of OM. Compared with those without any OM, patients with OM had a lower mean baseline CD4+ T cells count (CD4 count) (331 ± 260 versus 179 ± 244 CD4 cells/mm(3) ) and higher mean baseline HIV-1 RNA viral load (4.0 ± 1.34 log(10) versus 4.6 ± 1.30 log(10) ) (P < 0.01). In the logistic regression models seeking to determine factors associated with an increased risk of OM and OPC, the only characteristic associated with the outcome was baseline CD4 value. Being male, African-American, and heterosexual showed a protective role for OM other than OPC.
CONCLUSION: OM continues to be common despite HAART. General OM and OPC were closely associated with a low baseline CD4 count. Knowledge of risk factors for OM can potentially help clinicians target oral evaluation of HIV-positive individuals.
© 2011 American Association of Public Health Dentistry.

Entities:  

Mesh:

Year:  2011        PMID: 22320283     DOI: 10.1111/j.1752-7325.2011.00256.x

Source DB:  PubMed          Journal:  J Public Health Dent        ISSN: 0022-4006            Impact factor:   1.821


  5 in total

Review 1.  Periodontal and other oral manifestations of immunodeficiency diseases.

Authors:  M E Peacock; R M Arce; C W Cutler
Journal:  Oral Dis       Date:  2016-10-10       Impact factor: 3.511

Review 2.  Reusing electronic patient data for dental clinical research: a review of current status.

Authors:  Mei Song; Kaihong Liu; Rebecca Abromitis; Titus L Schleyer
Journal:  J Dent       Date:  2013-04-18       Impact factor: 4.379

3.  Decreased ratio of influenza-specific IgG versus IgM in response to influenza vaccination in antiretroviral-treated HIV-infected African Americans compared to Caucasians, and its direct correlation with the percentages of peripheral Tfh cells.

Authors:  Ping Ma; Zhenwu Luo; Jing Qian; Zhongfang Yan; Lumin Zhang; Lisa Martin; Ziyu Wang; Huan Xia; Fangfang Yu; Wei Jiang
Journal:  Vaccine       Date:  2020-01-14       Impact factor: 3.641

4.  Design aspects of a case-control clinical investigation of the effect of HIV on oral and gastrointestinal soluble innate factors and microbes.

Authors:  Joan A Phelan; William R Abrams; Robert G Norman; Yihong Li; Maura Laverty; Patricia M Corby; Jason Nembhard; Dinah Neri; Cheryl A Barber; Judith A Aberg; Gene S Fisch; Michael A Poles; Daniel Malamud
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

Review 5.  Oropharyngeal Candidosis in HIV-Infected Patients-An Update.

Authors:  Shankargouda Patil; Barnali Majumdar; Sachin C Sarode; Gargi S Sarode; Kamran H Awan
Journal:  Front Microbiol       Date:  2018-05-15       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.